Reply to: HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications
Eur Respir J
.
2026 Mar 5;67(3):2502523.
doi: 10.1183/13993003.02523-2025.
Print 2026 Mar.
Authors
Christian Kraef
1
,
Lene Ryom
2
,
Ole Kirk
3
2
;
writing group and the RESPOND study group
Affiliations
1
Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark christian.kraef.01@regionh.dk.
2
Centre of Excellence for Health, Immunity and Infections, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
3
Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
PMID:
41786493
DOI:
10.1183/13993003.02523-2025
No abstract available
Publication types
Letter
Comment